Literature DB >> 11847923

Microvascular complications in South African patients with long-duration diabetes mellitus.

A A Motala1, F J Pirie, E Gouws, A Amod, M A Omar.   

Abstract

OBJECTIVE: To determine the prevalence of microvascular complications in South African black and Indian patients with long-duration diabetes mellitus (DM).
DESIGN: A retrospective analysis was undertaken of clinical records of 219 DM patients (132 black, 87 Indian) with long-duration DM (over 10 years) attending a diabetes clinic in Durban. Data recorded on each subject included demographic details (age, gender, ethnic group, type of diabetes, age of onset and duration of diabetes), presence of retinopathy, markers of nephropathy and biochemical variables. The prevalence of complications and the clinical and biochemical parameters were evaluated for type 1 and type 2 diabetes and for each ethnic group.
RESULTS: Of the 219 patients, 47 had type 1 DM (36 blacks, 11 Indians) and 172 were classified as type 2 DM (96 blacks, 76 Indians). The mean age of onset of DM was later in blacks than Indians, both for type 1 (P < 0.05) and type 2 DM (P < 0.01). In patients with type 1 DM, the prevalence of retinopathy was 53.2% (blacks 55.6%, Indians 45.5%), persistent proteinuria was found in 23.4% (blacks 25%, Indians 18.2%) and hypertension in 34%. No ethnic difference was found except for the prevalence of hypertension which was higher in blacks than Indians (41.7% v. 9.1%, P < 0.5). Onset of retinopathy from time of diabetes diagnosis occurred earlier in blacks than Indians (13.0 +/- 4.6 yrs v. 18.0 +/- 4.6 yrs, P < 0.05). For the type 2 DM group, retinopathy was found in 64.5% (black v. Indian 68.8 v. 59.2%) and persistent proteinuria in 25% (black v. Indian 30.2 v. 18.4%). Hypertension was observed in 68% and was more prevalent in blacks (84.4 v. 47.4%, P < 0.01) There was an earlier onset of retinopathy (P < 0.05) and hypertension (P < 0.01) from time of diabetes diagnosis in blacks than Indians. In the type 1 DM group retinopathy was associated with a significantly longer duration of diabetes (P < 0.05) and higher glycated haemoglobin (HbA1) (P < 0.05). For type 2 DM subjects there was a significant association between retinopathy and longer duration of diabetes (P < 0.05) and higher systolic blood pressure (P < 0.05).
CONCLUSION: This study has shown that there is a high prevalence of microvascular complications in South African patients with long-duration diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11847923

Source DB:  PubMed          Journal:  S Afr Med J


  14 in total

1.  Diabetic nephropathy in Africa: A systematic review.

Authors:  Jean Jacques N Noubiap; Jashira Naidoo; Andre P Kengne
Journal:  World J Diabetes       Date:  2015-06-10

2.  A survey of the management, control, and complications of diabetes mellitus in patients attending a diabetes clinic in Blantyre, Malawi, an area of high HIV prevalence.

Authors:  Danielle B Cohen; Theresa J Allain; Simon Glover; Daniel Chimbayo; Helen Dzamalala; Helma W C Hofland; Ndaziona P K Banda; Eduard E Zijlstra
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study.

Authors:  Adam D Lewis; Ruth E Hogg; Manju Chandran; Lillian Musonda; Lorraine North; Usha Chakravarthy; Sobha Sivaprasad; Geeta Menon
Journal:  Eye (Lond)       Date:  2018-03-05       Impact factor: 3.775

4.  Genomic ancestry as a risk factor for diabetic retinopathy in patients with type 1 diabetes from an admixed population: a nested case-control study in Brazil.

Authors:  Deborah Conte Santos; Laura Gomes Nunes de Melo; Marcela Haas Pizarro; Bianca S V Barros; Carlos Antonio Negrato; Luís Cristóvão Porto; Dayse A Silva; Karla Rezende Guerra Drummond; Luiza Harcar Muniz; Tessa Cerqueria Lemos Mattos; André Araújo Pinheiro; Felipe Mallmann; Franz Schubert Lopes Leal; Fernando Korn Malerbi; Paulo Henrique Morales; Marília Brito Gomes
Journal:  Acta Diabetol       Date:  2020-03-03       Impact factor: 4.280

5.  Impaired reduction of nocturnal systolic blood pressure and severity of diabetic retinopathy.

Authors:  João Soares Felício; Juliana Torres Pacheco; Sandra Roberta Ferreira; Frida Plavnik; Valdir Moisés; Oswaldo Kohlmann Junior; Artur Beltrame Ribeiro; Maria Tereza Zanella
Journal:  Exp Clin Cardiol       Date:  2007

Review 6.  Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review.

Authors:  Victoria Hall; Reimar W Thomsen; Ole Henriksen; Nicolai Lohse
Journal:  BMC Public Health       Date:  2011-07-14       Impact factor: 3.295

7.  Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations.

Authors:  Sally N Adebamowo; Adebowale A Adeyemo; Fasil Tekola-Ayele; Ayo P Doumatey; Amy R Bentley; Guanjie Chen; Jie Zhou; Daniel Shriner; Olufemi Adetola Fasanmade; Godfrey Okafor; Benjamin Eghan; Kofi Agyenim-Boateng; Jokotade Adeleye; Williams Balogun; Albert G Amoah; Samuel Owusu; Joseph Acheampong; Thomas Johnson; Johnnie Oli; Clement A Adebamowo; Charles N Rotimi
Journal:  Front Endocrinol (Lausanne)       Date:  2016-05-30       Impact factor: 5.555

8.  Multi-ethnic differences in HbA1c, blood pressure, and low-density-lipid cholesterol control among South Africans living with type 2 diabetes, after a 4-year follow-up.

Authors:  Yacob Pinchevsky; Varada J Shukla; Neil Butkow; Tobias Chirwa; Frederick Raal
Journal:  Int J Gen Med       Date:  2016-11-16

9.  Retinopathy in subjects with type 2 diabetes at a tertiary diabetes clinic in Durban, South Africa: Clinical, biochemical and genetic factors.

Authors:  F J Pirie; S Maharaj; T M Esterhuizen; I M Paruk; A A Motala
Journal:  J Clin Transl Endocrinol       Date:  2013-12-19

10.  The non-fatal disease burden caused by type 2 diabetes in South Africa, 2009.

Authors:  Melanie Y Bertram; Aneil V S Jaswal; Victoria Pillay Van Wyk; Naomi S Levitt; Karen J Hofman
Journal:  Glob Health Action       Date:  2013-01-24       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.